Dvax earnings estimate
Web4 rows · Apr 6, 2024 · Dynavax Technologies Corporation (DVAX) latest earnings report: revenue, EPS, surprise, history, ... Web23.17R USD +13.36 +136.15% The 6 analysts offering 1 year price forecasts for Dynavax Technologies Corporation have a max estimate of 27.00 and a min estimate of 18.00. Analyst rating Based on 6 analysts giving stock ratings to Dynavax Technologies Corporation in the past 3 months. Neutral Sell Buy Strong sell Strong buy Strong buy …
Dvax earnings estimate
Did you know?
Web1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Dynavax Technologies (DVAX) WebOn Invalid Date, Dynavax Technologies (NASDAQ: DVAX) reported Q4 2024 earnings per share (EPS) of $0.53, up 35.37% year over year. Total Dynavax Technologies earnings for …
WebOct 30, 2024 · Dynavax Technologies (DVAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. ... Earnings Whisper. Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming … WebFeb 28, 2024 · Dynavax Technologies missed estimated earnings by 20.29%, reporting an EPS of $0.55 versus an estimate of $0.69. Revenue was up $175.52 million from the same period last year. Past Earnings...
WebDVAX Complete Dynavax Technologies Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Web2 days ago · DVAX: Dynavax Technologies Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. DVAX: Dynavax Technologies - …
WebAnalysts Offer Insights on Healthcare Companies: Dynavax (DVAX) and Blackmores Limited (OtherBLMMF) Feb. 28, 2024 at 10:50 a.m. ET on TipRanks.com Viatris' (VTRS) Q4 Earnings In-Line, Revenues...
WebNov 4, 2024 · Dynavax Technologies, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $108.27 million for the quarter ended September 2024, surpassing the Zacks Consensus... ttb1020b s4x sWeb2 days ago · Brian Evans. CNBC. Stocks jumped Thursday as traders cheered another report pointing to cooling U.S. inflation. The S&P 500 climbed 1.33% to 4,146.22 for its highest close since February. The ... ttb13c2204aWebApr 29, 2024 · Zacks Consensus Estimate This biopharmaceutical company is expected to post quarterly loss of $0.02 per share in its upcoming report, which represents a year-over-year change of +94.3%. Revenues... phoebe phantasticWebOct 28, 2024 · Zacks Consensus Estimate This biopharmaceutical company is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of +133.3%.... ttb060d100a0 air conditioner xb1000WebNovavax Inc $7.59 NVAX3.41% Tonix Pharmaceuticals Holding Corp $0.59 TNXP3.96% Aurinia Pharmaceuticals Inc $9.98 AUPH1.67% CymaBay Therapeutics Inc $8.55 CBAY0.70% Ardelyx Inc $4.43 ARDX1.77%... ttb13c2302aWebJul 28, 2024 · Zacks Consensus Estimate This biopharmaceutical company is expected to post quarterly loss of $0.04 per share in its upcoming report, which represents a year-over … ttb13c2205aWebApr 11, 2024 · Dynavax Technologies (NASDAQ:DVAX - Get Rating) last issued its quarterly earnings data on Thursday, February 23rd. The biopharmaceutical company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.01). Dynavax Technologies had a return on equity of 65.26% and a net margin of 40.56%. ttb1800prw manual